Primer: Medtide (3880 HK) - Aug 2026
Pure-Play Peptide CRDMO Positioned for Sector Tailwinds: Medtide is a specialized Contract Research, Development, and Manufacturing...
105 Views
𝛼SK or SearchENTITY
Medtide (3880 HK)
Medtide (3880 HK)
6
Analysis
Health Care • China
Medtide is a China-based, peptide-focused contract research, development, and manufacturing organization (CRDMO). It offers full-cycle services from early-stage discovery, preclinical research, and clinical development to commercial-stage production of peptide new chemical entities (NCEs) and active pharmaceutical ingredients (APIs). The company was founded in 2020 and is headquartered in Hangzhou, China.
morex